Bancroft Robert E. — SEC insider filings

SEC reporting owner CIK 2066370. 4 insider filings on record with FilingPulse; latest filed 2026-11-20.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2025-05-01 to 2026-11-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
AEON Biopharma, Inc. (AEON)President and CEO, Director41 leg · 152,333 sh · $19,590—3

Insider filings — Bancroft Robert E.

FiledFormIssuerReported transactionsSource
2026-11-204AEON Biopharma, Inc. (AEON)Purchase (P): 152,333 @ $0.13EDGAR
2026-02-194AEON Biopharma, Inc. (AEON)Grant/award (A): 3,000,000 @ $0EDGAR
2025-05-164AEON Biopharma, Inc. (AEON)Grant/award (A): 177,103 @ $0EDGAR
2025-05-014AEON Biopharma, Inc. (AEON)Grant/award (A): 59,034 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2066370 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs